AD2000: design and conclusions
- PMID: 15464172
- DOI: 10.1016/S0140-6736(04)17127-4
AD2000: design and conclusions
Comment on
-
AD2000: donepezil in Alzheimer's disease.Lancet. 2004 Jun 26;363(9427):2100-1. doi: 10.1016/S0140-6736(04)16533-1. Lancet. 2004. PMID: 15220027 No abstract available.
-
Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.Lancet. 2004 Jun 26;363(9427):2105-15. doi: 10.1016/S0140-6736(04)16499-4. Lancet. 2004. PMID: 15220031 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
